⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Insulin lispro

انسولین لیسپرو

⚠ Unverified

🍽️ Alimentary Tract And MetabolismRapid-acting insulin

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 👶 Children:Use with caution 👴 Older adults:Use with caution 🇮🇷 Not found in Iran list ⛔ 1 contraindications 🇺🇸 FDA approved (BLA) BLA020563 ATC A10AB04

Market / country: 🇺🇸 USA

Humalog (US)

🧮 Dose calculator

Disease / regimen

Type 1 diabetes · Regimen source: FDA Humalog · 2.3 FDA Humalog · 2.1

⛔ Label: individualise by metabolic needs, glucose monitoring and goals. SC within 15 min before or right after a meal; usually with a basal insulin. U-200 only in its own pen. FDA Humalog · 2.3 FDA Humalog · 2.1

🛡️ Safety & information

Contraindications

⛔ During episodes of hypoglycaemia; hypersensitivity to the insulin or its excipients. FDA Humalog · 4

Warnings

• Hypoglycaemia; hypokalaemia; never share pens or syringes. FDA Humalog · 5

Formulations

100 units/mL (U-100) vial, cartridge or KwikPen — injection 🇺🇸 USA FDA Humalog · 3
200 units/mL (U-200) KwikPen — injection 🇺🇸 USA FDA Humalog · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Humalog · 8.1
“Risk Summary Published studies with insulin lispro used during pregnancy have not reported an association between insulin lispro and the induction of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data) .”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Humalog · 8.2
“Risk Summary Available data from published literature suggests that exogenous human insulin products, including insulin lispro, are transferred into human milk.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Humalog · 8.4
“The safety and effectiveness of HUMALOG to improve glycemic control have been established in pediatric patients with diabetes mellitus.”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Humalog · 8.5
“Of the total number of patients (n=2,834) in eight clinical studies of HUMALOG, twelve percent (n=338) were 65 years of age or over.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)BLA020563
DailyMed (FDA label)FDA Humalog
MedlinePlus (NIH)Insulin Lispro Injection
WHO ATC/DDDA10AB04
Darooyab (Iran)❌ None

🇮🇷 Not found in Iran list Darooyab · search

Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Humalog · 3 FDA Humalog · 2.3 FDA Humalog · 2.1 FDA Humalog · 4 FDA Humalog · 5 FDA Humalog · 8.1 FDA Humalog · 8.2 FDA Humalog · 8.4 FDA Humalog · 8.5 FDA Humalog · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · search
Clinical review⚠ Unverified